Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,533Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Nexavar

02 1NexavarTM

PharmaCompass

01

Brand Name : Nexavar

Sorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nexavar

arrow
Antibody Engineering
Not Confirmed

Sorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 773

2019 Revenue in Millions : 854

Growth (%) : -9

blank

02

Brand Name : Nexavar

Sorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nexavar

arrow
Antibody Engineering
Not Confirmed

Sorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 479

2020 Revenue in Millions : 773

Growth (%) : -32

blank

03

Brand Name : Nexavar

Sorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nexavar

arrow
Antibody Engineering
Not Confirmed

Sorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 280

2021 Revenue in Millions : 479

Growth (%) : -41

blank

04

Brand Name : Nexavar

Sorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nexavar

arrow
Antibody Engineering
Not Confirmed

Sorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 850

2014 Revenue in Millions : 981

Growth (%) : 15%

blank

05

Brand Name : NexavarTM

Sorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : NexavarTM

arrow
Antibody Engineering
Not Confirmed

Sorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2014 Revenue in Millions : 0.30%

2013 Revenue in Millions :

Growth (%) :

blank

06

Brand Name : Nexavar

Sorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nexavar

arrow
Antibody Engineering
Not Confirmed

Sorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 1,034

2016 Revenue in Millions : 1,079

Growth (%) : -4

blank

07

Brand Name : Nexavar

Sorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nexavar

arrow
Antibody Engineering
Not Confirmed

Sorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 922

2015 Revenue in Millions : 946

Growth (%) : -2

blank

08

Brand Name : Nexavar

Sorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nexavar

arrow
Antibody Engineering
Not Confirmed

Sorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 805

2017 Revenue in Millions : 942

Growth (%) : -15%

blank

09

Brand Name : Nexavar

Sorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nexavar

arrow
Antibody Engineering
Not Confirmed

Sorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 770

2018 Revenue in Millions : 776

Growth (%) : -1

blank